• Most Popular
  • Most Shared

U.S. FDA approves migraine drug from Glaxo, Pozen

Tue Apr 15, 2008 9:12pm EDT

Stocks

   

NEW YORK, April 15 (Reuters) - The U.S. Food and Drug Administration has approved a combination migraine drug from GlaxoSmithKline Plc (GSK.L) (GSK.N) and Pozen Inc (POZN.O), the companies said on Tuesday.

Stocks  |  Regulatory News  |  Global Markets

The drug, Treximet, is expected to be available in U.S. pharmacies by the middle of May, the companies said.

FDA officials had earlier expressed concern over heart safety and the risk of gene toxicity, asking for more data. (Reporting by Justin Grant, with additional reporting by Susan Heavey in Washington; Editing by Braden Reddall)

Stocks
Regulatory News
Global Markets


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets